65.20
Dexcom Inc stock is traded at $65.20, with a volume of 3.29M.
It is up +0.12% in the last 24 hours and down -14.46% over the past month.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$65.12
Open:
$65.99
24h Volume:
3.29M
Relative Volume:
0.71
Market Cap:
$25.57B
Revenue:
$4.30B
Net Income/Loss:
$571.50M
P/E Ratio:
45.64
EPS:
1.4285
Net Cash Flow:
$570.80M
1W Performance:
-1.75%
1M Performance:
-14.46%
6M Performance:
-1.42%
1Y Performance:
-5.79%
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DXCM
Dexcom Inc
|
65.20 | 25.54B | 4.30B | 571.50M | 570.80M | 1.4285 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
Aug-21-25 | Initiated | Argus | Buy |
Jun-16-25 | Initiated | Truist | Buy |
May-30-25 | Initiated | Goldman | Buy |
Apr-10-25 | Initiated | Mizuho | Outperform |
Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-30-24 | Initiated | Redburn Atlantic | Neutral |
Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Mar-29-23 | Initiated | UBS | Buy |
Jan-26-23 | Initiated | Wolfe Research | Outperform |
Oct-18-22 | Initiated | Barclays | Equal Weight |
Oct-12-22 | Initiated | Jefferies | Buy |
Jul-15-22 | Initiated | Bernstein | Outperform |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
Jul-21-21 | Resumed | Cowen | Outperform |
May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
May-25-21 | Initiated | Barclays | Overweight |
Apr-15-21 | Initiated | Atlantic Equities | Overweight |
Jan-06-21 | Upgrade | UBS | Neutral → Buy |
Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
May-27-20 | Reiterated | Piper Sandler | Overweight |
May-14-20 | Initiated | Wells Fargo | Equal Weight |
Mar-05-20 | Initiated | Citigroup | Buy |
Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
Oct-23-19 | Initiated | Stifel | Buy |
Nov-28-18 | Initiated | UBS | Neutral |
Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
May-11-18 | Initiated | BofA/Merrill | Buy |
May-03-18 | Reiterated | Canaccord Genuity | Buy |
Apr-04-18 | Initiated | Goldman | Sell |
Apr-04-18 | Initiated | Guggenheim | Neutral |
Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
Will DexCom Inc. stock maintain momentum in 2025Earnings Beat & AI Enhanced Trading Alerts - newser.com
Is DexCom Inc. stock reversal real or fakeInsider Buying & Comprehensive Market Scan Insights - newser.com
Key metrics from DexCom Inc.’s quarterly dataWeekly Investment Recap & Weekly Top Stock Performers List - newser.com
What catalysts could drive DexCom Inc. stock higher2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
DexCom Earnings Preview: What to Expect - MSN
Is DexCom Inc. stock ready for a breakoutWatch List & Verified Momentum Stock Alerts - newser.com
DexCom Earnings Preview: What To Expect - Barchart.com
DexCom Inc. stock chart pattern explainedJuly 2025 Snapshot & Daily Entry Point Alerts - newser.com
What MACD and RSI say about DexCom Inc.July 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Is DexCom Inc. a candidate for recovery playWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
What does recent volatility data suggest for DexCom Inc.Options Play & Low Volatility Stock Recommendations - newser.com
Vontobel Holding Ltd. Has $1.15 Million Stake in DexCom, Inc. $DXCM - MarketBeat
DSM Capital Partners LLC Has $125.29 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
Callan Family Office LLC Buys 16,443 Shares of DexCom, Inc. $DXCM - MarketBeat
Combining price and volume data for DexCom Inc.Analyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know - TradingView
Will DexCom Inc. benefit from macro trendsSell Signal & Technical Analysis for Trade Confirmation - newser.com
Can DexCom Inc. (DC4) stock sustain double digit ROEWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Real time scanner hits for DexCom Inc. explained2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
What MACD trends signal for DexCom Inc. (DC4) stockEarnings Summary Report & Community Driven Trade Alerts - newser.com
Blair William & Co. IL Lowers Position in DexCom, Inc. $DXCM - MarketBeat
Why DexCom Inc. stock remains on watchlistsPortfolio Risk Report & Entry Point Confirmation Alerts - newser.com
DexCom Inc. stock trend forecastJuly 2025 Catalysts & Capital Efficiency Focused Strategies - newser.com
DexCom (NASDAQ:DXCM) Receives Hold (C-) Rating from Weiss Ratings - MarketBeat
Is it too late to sell DexCom Inc.2025 Investor Takeaways & Target Return Focused Picks - newser.com
Is DexCom Inc. (DC4) stock resilient in recession scenarios2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Can DexCom Inc. stock deliver sustainable ROEWeekly Stock Report & Low Drawdown Investment Strategies - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - PR Newswire
DexCom Inc Stock Analysis and ForecastIPO Market Watch & Exceptional Capital Trading - earlytimes.in
Shell Asset Management Co. Buys 5,138 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Stake Raised by DAVENPORT & Co LLC - MarketBeat
Janney Montgomery Scott LLC Trims Stake in DexCom, Inc. $DXCM - MarketBeat
William Blair Maintains Bullish Stance on DexCom (DXCM) Stock - Yahoo
Citigroup Issues Pessimistic Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
DexCom (DXCM): Citigroup Lowers Price Target, Maintains "Buy" Ra - GuruFocus
What analysts say about DexCom Inc DC4 stockSector Performance Drivers & Diversify Intelligently to Avoid Big Hits - earlytimes.in
Applying big data sentiment scoring on DexCom Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Comprehensive Financial Consultants Institutional Inc. Grows Position in DexCom, Inc. $DXCM - MarketBeat
Can DexCom Inc. (DC4) stock deliver consistent EPS growthWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
DexCom May Be The Most Underrated Growth Story In Healthcare (NASDAQ:DXCM) - Seeking Alpha
What dividend safety rating applies to DexCom Inc. (DC4) stockEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
DexCom, Inc. $DXCM Shares Purchased by Sendero Wealth Management LLC - MarketBeat
DexCom (DXCM): Valuation Insights as G7 Reliability Improves and Reimbursement Expands - Sahm
DexCom, Inc. Reports Second Quarter 2017 Financial Results - ADVFN
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dexcom Inc Stock (DXCM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Stern Sadie | EVP, Chief HR Officer |
Sep 04 '25 |
Sale |
80.00 |
1,466 |
117,280 |
105,223 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):